SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-21-016269
Filing Date
2021-07-06
Accepted
2021-07-06 17:14:50
Documents
17

Document Format Files

Seq Description Document Type Size
1 forms-1.htm S-1 2562737
2 ex3-1.htm EX-3.1 27016
3 ex3-2.htm EX-3.2 39516
4 ex3-3.htm EX-3.3 93717
5 ex3-4.htm EX-3.4 119779
6 ex10-1.htm EX-10.1 472618
7 ex10-6.htm EX-10.6 104153
8 ex10-7.htm EX-10.7 135175
9 ex10-8.htm EX-10.8 145596
10 ex21-1.htm EX-21.1 1303
11 ex23-1.htm EX-23.1 3988
12 forms-1_001.jpg GRAPHIC 83719
13 f_001.jpg GRAPHIC 13530
14 forms-1_002.jpg GRAPHIC 9770
15 forms-1_003.jpg GRAPHIC 12163
16 forms-1_004.jpg GRAPHIC 52065
17 forms-1_005.jpg GRAPHIC 83719
  Complete submission text file 0001493152-21-016269.txt   4058202
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-257722 | Film No.: 211075084
SIC: 2834 Pharmaceutical Preparations